Outcome of cord-blood transplantation from related and unrelated donors

被引:1041
作者
Gluckman, E
Rocha, V
BoyerChammard, A
Locatelli, F
Arcese, W
Pasquini, R
Ortega, J
Souillet, G
Ferreira, E
Laporte, JP
Fernandez, M
Chastang, C
机构
[1] UNIV PAVIA,I-27100 PAVIA,ITALY
[2] UNIV ROMA LA SAPIENZA,ROME,ITALY
[3] HOSP CLIN,CURITIBA,PARANA,BRAZIL
[4] HOSP VALLE DE HEBRON,BARCELONA,SPAIN
[5] HOP DEBROUSSE,LYON,FRANCE
[6] HOSP ALBERT EINSTEIN,SAO PAULO,BRAZIL
[7] HOP ST ANTOINE,F-75571 PARIS,FRANCE
[8] CLIN PUERTA HIERRO,MADRID,SPAIN
关键词
D O I
10.1056/NEJM199708073370602
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Cord-blood banks have increased the use of cord-blood transplantation in patients with hematologic disorders. We have established a registry containing information on the outcome of cord-blood transplantation. Methods We sent questionnaires to 45 transplantation centers for information on patients receiving cord-blood transplants from 1988 to 1996. Reports on 143 transplantations, performed at 45 centers, were studied, and the responses were analyzed separately according to whether the donor was related or unrelated to the recipient. Results Among 78 recipients of cord blood from related donors, the Kaplan-Meier estimate of survival at one year was 63 percent. Younger age, lower weight, transplants from HLA-identical donors, and cytomegalovirus-negative serologic results in the recipient were favorable prognostic factors. Graft-versus-host disease of at least grade II occurred at estimated rates of 9 percent in 60 recipients of HLA-matched cord blood and 50 percent in 18 recipients of HLA-mismatched cord blood. Neutrophil engraftment was associated with an age of less than six years (P = 0.02) and a weight of less than 20 kg (P = 0.02), and it occurred in 85 percent of patients receiving 37 million or more nucleated cells per kilogram of body weight. Among 65 patients who received cord blood from unrelated donors, the Kaplan-Meier estimate of survival at one year was 29 percent. Cytomegalovirus-negative serologic status in these recipients was associated with improved survival (P = 0.03) and was the most important predictor of graft-versus-host disease (P = 0.04). Neutrophil recovery occurred in 94 percent of the patients who received 37 million or more nucleated cells per kilogram from unrelated donors. Conclusions Cord blood is a feasible alternative source of hematopoietic stem cells for pediatric and some adult patients with major hematologic disorders, particularly if the donor and the recipient are related. (C) 1997, Massachusetts Medical Society.
引用
收藏
页码:373 / 381
页数:9
相关论文
共 24 条
  • [1] Placental blood transplant: Who will benefit?
    Brenner, M
    [J]. NATURE MEDICINE, 1996, 2 (09) : 969 - 970
  • [2] GROWTH-CHARACTERISTICS AND EXPANSION OF HUMAN UMBILICAL-CORD BLOOD AND ESTIMATION OF ITS POTENTIAL FOR TRANSPLANTATION IN ADULTS
    BROXMEYER, HE
    HANGOC, G
    COOPER, S
    RIBEIRO, RC
    GRAVES, V
    YODER, M
    WAGNER, J
    VADHANRAJ, S
    BENNINGER, L
    RUBINSTEIN, P
    BROUN, ER
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) : 4109 - 4113
  • [3] HUMAN UMBILICAL-CORD BLOOD AS A POTENTIAL SOURCE OF TRANSPLANTABLE HEMATOPOIETIC STEM PROGENITOR CELLS
    BROXMEYER, HE
    DOUGLAS, GW
    HANGOC, G
    COOPER, S
    BARD, J
    ENGLISH, D
    ARNY, M
    THOMAS, L
    BOYSE, EA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) : 3828 - 3832
  • [4] Newborn blood can engraft adult mice without inducing graft-versus-host disease across non H-2 antigens
    deLaSelle, V
    Gluckman, E
    BruleyRosset, M
    [J]. BLOOD, 1996, 87 (09) : 3977 - 3983
  • [5] HEMATOPOIETIC RECONSTITUTION IN A PATIENT WITH FANCONIS ANEMIA BY MEANS OF UMBILICAL-CORD BLOOD FROM AN HLA-IDENTICAL SIBLING
    GLUCKMAN, E
    BROXMEYER, HE
    AUERBACH, AD
    FRIEDMAN, HS
    DOUGLAS, GW
    DEVERGIE, A
    ESPEROU, H
    THIERRY, D
    SOCIE, G
    LEHN, P
    COOPER, S
    ENGLISH, D
    KURTZBERG, J
    BARD, J
    BOYSE, EA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (17) : 1174 - 1178
  • [6] Patents versus transplants
    Gluckman, E
    OReilly, R
    Wagner, J
    Rubinstein, P
    [J]. NATURE, 1996, 382 (6587) : 108 - 108
  • [7] GLUCKMAN E, 1995, ONTOGENY HAEMOTOPOIE, V235, P183
  • [8] CLINICAL MANIFESTATIONS OF GRAFT VERSUS HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONORS
    GLUCKSBERG, H
    STORB, R
    FEFER, A
    BUCKNER, CD
    NEIMAN, PE
    CLIFT, RA
    LERNER, KG
    THOMAS, ED
    [J]. TRANSPLANTATION, 1974, 18 (04) : 295 - 304
  • [9] Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients
    Kurtzberg, J
    Laughlin, M
    Graham, ML
    Smith, C
    Olson, JF
    Halperin, EC
    Ciocci, G
    Carrier, C
    Stevens, CE
    Rubinstein, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (03) : 157 - 166
  • [10] Private cord blood banks raise concern
    Marshall, E
    [J]. SCIENCE, 1996, 271 (5249) : 587 - 587